Possible transmission of parvovirus B19 from intravenous immune globulin.

Erdman, D D; Anderson, B C; Török, T J; Finkel, T H; Anderson, L J

Erdman, D D; Anderson, B C; Török, T J; Finkel, T H; Anderson, L J.

Affiliation

Erdman DD; Centers for Disease Control and Prevention, U.S. Department of Health and Human Services, Atlanta, Georgia 30333, USA. dde1@cdc.gov

J Med Virol ; 53(3): 233-6, 1997 Nov.

Article in En | MEDLINE | ID: mdl-9365888

Subject(s)

Capsid Proteins; Immunoglobulins, Intravenous/adverse effects; Papillomavirus Infections/transmission; Parvovirus B19, Human; Antibodies, Viral/blood; Capsid/genetics; Child, Preschool; DNA, Viral; Drug Contamination; Humans; Male; Papillomavirus Infections/blood; Papillomavirus Infections/immunology; Parvovirus B19, Human/genetics; Parvovirus B19, Human/isolation & purification; Vasculitis/blood; Vasculitis/immunology; Vasculitis/virology

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Parvovirus B19, Human / Immunoglobulins, Intravenous / Papillomavirus Infections / Capsid Proteins Limits: Child, preschool / Humans / Male Language: En Journal: J Med Virol Year: 1997 Document type: Article Affiliation country: United States Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links